Sachpekidis, C., Kopp-Schneider, A., Hakim-Meibodi, L., Dimitrakopoulou-Strauss, A., & Hassel, J. C. (2019). 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab. Melanoma research, 29(2), . https://doi.org/10.1097/CMR.0000000000000541
Chicago Style (17th ed.) CitationSachpekidis, Christos, Annette Kopp-Schneider, Lara-Elena Hakim-Meibodi, Antonia Dimitrakopoulou-Strauss, and Jessica C. Hassel. "18F-FDG PET/CT Longitudinal Studies in Patients with Advanced Metastatic Melanoma for Response Evaluation of Combination Treatment with Vemurafenib and Ipilimumab." Melanoma Research 29, no. 2 (2019). https://doi.org/10.1097/CMR.0000000000000541.
MLA (9th ed.) CitationSachpekidis, Christos, et al. "18F-FDG PET/CT Longitudinal Studies in Patients with Advanced Metastatic Melanoma for Response Evaluation of Combination Treatment with Vemurafenib and Ipilimumab." Melanoma Research, vol. 29, no. 2, 2019, https://doi.org/10.1097/CMR.0000000000000541.